Myonex Acquires Hubertus Apotheke Clinical Trial and Packaging Business

Myonex Acquires Creapharm's Pharmaceutical Services Business

May 2, 2024

Pharmaceuticals

Myonex has completed the acquisition of Creapharm's pharmaceutical services business, integrating Creapharm's clinical packaging, commercial packaging and bioservices into its global clinical trial supply platform. The deal brings Creapharm's cold-chain and ultra-cold capabilities and expands Myonex's service offering and European footprint; Creapharm founder Eric Placet has reinvested and joined the Myonex board.

AmerisourceBergen Acquires PharmaLex from AUCTUS in €1.28bn Transaction

December 31, 2022

Healthcare Services

AmerisourceBergen Corporation acquired a majority stake in PharmaLex from funds advised by AUCTUS Capital Partners AG in a transaction that closed at year-end 2022 for approximately EUR 1.28 billion. PharmaLex, a Germany-headquartered provider of regulatory, clinical development and pharmacovigilance services to the life sciences industry, was grown under AUCTUS through a buy-and-build program of 38 add-ons and will expand AmerisourceBergen's global pharmaceutical solutions.

Myonex Acquires SaveWay Compounding Pharmacy

April 10, 2024

Healthcare Services

Myonex has completed the acquisition of SaveWay Compounding Pharmacy, a Newark, Delaware-based compounding pharmacy, to expand its direct-to-patient and home healthcare capabilities for clinical trials across the United States. The purchase enhances Myonex's clinical trial supply offerings—adding compounding, drug sourcing and dispensing capabilities to support decentralized and hybrid trials nationwide.

Nexelis Acquires GSK Vaccines Clinical Bioanalytical Laboratory (Marburg)

January 20, 2021

Biotechnology

Nexelis, a portfolio company of Ampersand Capital Partners, has signed an asset purchase agreement to acquire GSK's GCLP-certified clinical bioanalytical laboratory in Marburg, Germany. Approximately 80 scientists and analysts will transfer to Nexelis, which also entered a five-year strategic collaboration with GSK to continue supporting vaccine development while expanding Nexelis' assay development and high-throughput clinical testing capabilities in Europe.

PharmaLex Group Merges with NeoHealthHub Limited

October 13, 2022

Healthcare Services

PharmaLex Group has merged with UK-based NeoHealthHub Limited to strengthen PharmaLex’s market access and data capabilities in the UK and build a pan‑European market access practice. NeoHealthHub, headquartered in Lutterworth, Leicestershire, employs around 50 people and will expand PharmaLex’s local market access, data and capability development offerings across major European markets.

Kymanox Acquires anteris medical GmbH and anteris helvetia AG

February 2, 2023

Professional Services

Kymanox Corporation has acquired anteris medical GmbH (Germany) and anteris helvetia AG (Switzerland) to expand its European footprint and broaden its life-science professional services capabilities. The deal brings additional regulatory, quality, and combination-product expertise to Kymanox; terms were not disclosed.